The multi-specialty, multi-application platform offers superior cost effectiveness to yield a high return on investment Extensive clinical evidence with over 14 randomized controlled trials

The standard of care for treating BPH (HoLAP & HoLEP) and stones (in all locations) - AUA and EAU support Versa Pulse as first line treatment option Precise and controlled cutting and ablation; penetrates just enough to ablate tissue without charring, deep thermal necrosis or collateral damage. Effective for minimally invasive procedures requiring soft tissue ablations